The Vinod Balachandran Lab: Featured News

Share
Share
Memorial Sloan Kettering physician-scientist Vinod Balachandran, who specializes in treating pancreatic cancer
Picking the Winners: Study Sheds Light on Possible Best Targets for Pancreatic Cancer Vaccine
Research confirms a sound strategy for designing a therapeutic vaccine for pancreatic cancer.
Could lab-grown organs and cancer vaccines be the future of medicine?
Lab-grown organs. AI-powered medical devices. Personalized mRNA vaccines that fight cancer. These may sound like science fiction, but the future of med...
African-American surgeon in scrubs and mask leaning over patient in OR.
2021 in Review: 10 Important Clinical Advances in Cancer at MSK
Learn about some of the most important clinical advances made at MSK in 2021.
Covid success of mRNA vaccines opens way to a new generation of drugs
While the mRNA vaccines made by BioNTech/Pfizer and Moderna have become synonymous with helping to dramatically reduce deaths from Covid-19, MSK's Vino...
MSK physician-scientist Vinod Balachandran.
MSK mRNA Pancreatic Cancer Vaccine Trial Shows Promising Results
Learn how MSK researchers are deploying mRNA vaccines against pancreatic cancer.
In the Lab
Surgeon-scientist Vinod Balachandran
What’s Next in Immunotherapy for Pancreatic Cancer? New Immune Cell Type May Be Key
Researchers find a potential new route to making immunotherapy work better in pancreatic cancers and possibly others.
Finding
An illustration of the human pancreas
Why Do Some People Beat the Odds against Pancreatic Cancer?
Scientists think they now understand why some people with pancreatic cancer survive for many years. Hint: It involves the immune system.